Advancing the Frontier of Immunotherapy
The full potential of the human immune system is yet to be unlocked. Prophylactic vaccines have been among the greatest achievements in human healthcare, demonstrating the power of natural immune responses when focused on the right targets. The next major advance in healthcare is upon us, as scientists expose chronic infections and cancers to the immune responses that can defeat them. Vedantra builds upon these advances, using the body’s natural immune responses against defined targets to create effective, durable, and safe therapies.

William Koster, PhD
Executive chairman

Satish Jindal, PhD
Co-founder and Director

Steven Deitcher, MD
Director

Isaac Kohlberg, MBA
Director

Darrell Irvine, PhD
Founder and Scientific Consultant

Mark Carthy, MBA
Business Advisor to Board

George Siber, MD
Consultant

Adrienne Li
Senior Scientist

Jack Eby
Senior Scientist

Peter DeMuth
Senior Scientist